LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer ...

The Dow Jones tracks 30 of the largest American companies across different sectors. Verizon, Chevron, and Merck hold the ...

If you are wondering whether Merck is still attractively priced today, or if the market has already priced in much of the ...

Vaxcyte aims to revolutionize the pneumococcal vaccine market with VAX-31. Click here to read an analysis of PCVX stock now.

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Merck (MRK) ended the recent trading session at $99.01, demonstrating a +1.42% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.21%. On the other hand, ...

As of Tuesday, December 09, Immutep Limited’s IMMP share price has dipped by 5.73%, which has investors questioning if this is right time to buy.

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

The latest mega deal is Netflix Inc.’s $72 billion capture of Warner Bros. Discovery Inc., for which it lined up $59 billion of financing from banks. Netflix’s bridge loan is expected to be eventually ...

Merck & Co., Inc. (NYSE: MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection ...

Cosmo Pharmaceuticals attracted welcome attention from investors and other market watchers after coming out with topline ...